| X24-06-ZQ042 |
c-MET inhibitor BMS-777607, Purity ≥98%
|
|
| X24-06-ZQ044 |
c-MET inhibitor CEP-40783, Purity ≥98%
|
|
| X24-06-ZQ049 |
c-MET inhibitor Glesatinib hydrochloride, Purity ≥98%
|
|
| X24-06-ZQ052 |
c-MET inhibitor NPS-1034, Purity ≥98%
|
|
| X24-06-ZQ196 |
c-MET inhibitor AMG 208, Purity ≥98%
|
|
| X24-06-ZQ197 |
c-MET inhibitor AMG 337, Purity ≥98%
|
|
| X24-06-ZQ198 |
c-MET inhibitor AMG-458, Purity ≥98%
|
|
| X24-06-ZQ199 |
c-MET inhibitor ARQ 197, Purity ≥98%
|
|
| X24-06-ZQ203 |
c-Met inhibitor 1, Purity ≥98%
|
|
| X24-06-ZQ204 |
c-Met inhibitor 2, Purity ≥98%
|
|
| X24-06-ZQ207 |
c-MET inhibitor EMD-1214063, Purity ≥98%
|
|
| X24-06-ZQ210 |
c-MET inhibitor SCC-244, Purity ≥98%
|
|
| X24-06-ZQ211 |
c-MET inhibitor INCB28060, Purity ≥98%
|
|
| X24-06-ZQ212 |
c-MET inhibitor JNJ-38877605, Purity ≥98%
|
|
| X24-06-ZQ213 |
c-MET inhibitor JNJ-38877618, Purity ≥98%
|
|
| X24-06-ZQ214 |
c-MET inhibitor LY2801653, Purity ≥98%
|
|
| X24-06-ZQ215 |
c-MET inhibitor LY2801653 dihydrochloride, Purity ≥98%
|
|
| X24-06-ZQ217 |
c-MET inhibitor MK-8033, Purity ≥98%
|
|
| X24-06-ZQ218 |
c-MET inhibitor NVP-BVU972, Purity ≥98%
|
|
| X24-06-ZQ219 |
c-MET inhibitor PF-04217903, Purity ≥98%
|
|
| X24-06-ZQ220 |
c-MET inhibitor PF-04217903 methanesulfonate, Purity ≥98%
|
|
| X24-06-ZQ221 |
c-MET inhibitor PF-2341066, Purity ≥98%
|
|
| X24-06-ZQ222 |
c-MET inhibitor PHA-665752, Purity ≥98%
|
|
| X24-06-ZQ223 |
c-MET inhibitor SGX-523, Purity ≥98%
|
|
| X24-06-ZQ224 |
c-MET inhibitor SU11274, Purity ≥98%
|
|
| X24-06-ZQ226 |
c-MET inhibitor Tivantinib, Purity ≥98%
|
|
| X24-06-ZQ227 |
c-MET inhibitor AZD-6094, Purity ≥98%
|
|
